Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

535 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation between the serum KL-6 level and the grade of radiation pneumonitis after stereotactic body radiotherapy for stage I lung cancer or small lung metastasis.
Iwata H, Shibamoto Y, Baba F, Sugie C, Ogino H, Murata R, Yanagi T, Otsuka S, Kosaki K, Murai T, Miyakawa A. Iwata H, et al. Among authors: kosaki k. Radiother Oncol. 2011 Nov;101(2):267-70. doi: 10.1016/j.radonc.2011.05.031. Epub 2011 Jun 2. Radiother Oncol. 2011. PMID: 21640420 No abstract available.
Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity.
Iwata H, Shibamoto Y, Hashizume C, Mori Y, Kobayashi T, Hayashi N, Kosaki K, Ishikawa T, Kuzuya T, Utsunomiya S. Iwata H, et al. Among authors: kosaki k. Technol Cancer Res Treat. 2010 Dec;9(6):619-27. doi: 10.1177/153303461000900610. Technol Cancer Res Treat. 2010. PMID: 21070084 Free article. Clinical Trial.
Radiotherapy for hilar or mediastinal lymph node metastases after definitive treatment with stereotactic body radiotherapy or surgery for stage I non-small cell lung cancer.
Manabe Y, Shibamoto Y, Baba F, Murata R, Yanagi T, Hashizume C, Iwata H, Kosaki K, Miyakawa A, Murai T, Yano M. Manabe Y, et al. Among authors: kosaki k. Pract Radiat Oncol. 2012 Oct-Dec;2(4):e137-e143. doi: 10.1016/j.prro.2011.11.007. Epub 2011 Dec 29. Pract Radiat Oncol. 2012. PMID: 24674177
Impact of advanced radiotherapy techniques and dose intensification on toxicity of salvage radiotherapy after radical prostatectomy.
Tomita N, Uchiyama K, Mizuno T, Imai M, Sugie C, Ayakawa S, Niwa M, Matsui T, Otsuka S, Manabe Y, Nomura K, Kondo T, Kosaki K, Miyakawa A, Miyamoto A, Takemoto S, Kitagawa Y, Yasui T, Shibamoto Y. Tomita N, et al. Among authors: kosaki k. Sci Rep. 2020 Jan 10;10(1):114. doi: 10.1038/s41598-019-57056-9. Sci Rep. 2020. PMID: 31924839 Free PMC article.
Early salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: Its impact and optimal candidate.
Tomita N, Uchiyama K, Mizuno T, Imai M, Sugie C, Ayakawa S, Niwa M, Matsui T, Otsuka S, Manabe Y, Nomura K, Kondo T, Kosaki K, Miyakawa A, Miyamoto A, Takemoto S, Yasui T, Shibamoto Y. Tomita N, et al. Among authors: kosaki k. Asia Pac J Clin Oncol. 2020 Aug;16(4):273-279. doi: 10.1111/ajco.13341. Epub 2020 Jun 9. Asia Pac J Clin Oncol. 2020. PMID: 32519506
535 results